Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted
Thesis Summary

3M entered the second half of 2026 with strong operating momentum: second-quarter adjusted organic sales grew 5.4%, adjusted margin reached 24.9%, adjusted EPS rose 11%, and management raised full-year adjusted EPS guidance to $8.80-$8.95. The operating recovery is credible, but the investment case remains balanced by $7.4 billion of recorded PFAS-related environmental liabilities, $1.9 billion of Combat Arms liabilities, weak Consumer organic sales, tariff and PFAS-exit cost pressure, and integration risk from the Madison Fire & Rescue transaction.

Sign in / Sign up to read more
This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.
Street view · analyst 12-month targets17 analysts · as of 18 Aug 2026
Low · most bearish analyst$120.00
Mean target$185.57
High · most bullish analyst$219.00
Street targets sit above today's price; our intrinsic value sits below it. Different horizons, different questions.
Our research · scenarios, merits, risks, and invalidation triggersResearch as of 2 Sep 2026
Scenarios · 12-month scenario targetsAnchored at research date
Bear CaseDownside scenario
$120.0023%

Adjusted organic growth falls below guidance as Consumer weakness spreads, tariffs and PFAS-exit dis-synergies prevent margin expansion, or Madison integration underperforms. A material increase in PFAS or other legal obligations would further reduce cash available for investment and shareholder returns.

Base CaseCentral scenario
$185.5758%
Matches the consensus mean

3M delivers adjusted EPS within $8.80-$8.95, achieves 70-80 basis points of adjusted margin expansion, and converts more than 100% of adjusted earnings to free cash flow. Industrial, safety, semiconductor, and data-center demand offset Consumer weakness, while legal liabilities remain manageable within existing accruals.

Bull CaseUpside scenario
$219.0019%

Commercial execution and innovation sustain growth above the >3.5% full-year organic objective, Safety and Industrial and Transportation and Electronics remain strong, and productivity delivers faster progress toward the approximately 25% 2027 margin objective. Stable legal accruals and successful Madison integration would support the upside case.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits
  • Second-quarter adjusted organic sales growth of 5.4%, adjusted margin of 24.9%, and adjusted EPS growth of 11% demonstrate improving execution.
  • Management raised FY2026 adjusted EPS guidance to $8.80-$8.95 and expects adjusted operating cash flow of $5.8-$6.0 billion with greater than 100% adjusted free-cash-flow conversion.
  • The medium-term framework targets approximately 25% operating margin by 2027, high-single-digit annual EPS growth, and at least $10 billion of shareholder cash returns over the outlook period.
Sign in / Sign up to read more
Key Investment Risks
  • At June 30, 2026, recorded PFAS-related environmental liabilities were $7.4 billion and Combat Arms liabilities were $1.9 billion; additional losses above accruals could not be estimated.
  • Consumer second-quarter organic sales declined 2.1%, with lower U.S. retailer inventories more than offsetting positive point-of-sale trends and share gains.
  • Tariffs, PFAS-exit cost dis-synergies, transformation execution, and the Madison Fire & Rescue integration could dilute expected margin and cash-flow improvement.
Sign in / Sign up to read more

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Explore this dossier

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.